With the rise of generative AI as an aid for design, this seminar discusses the intellectual property issues surrounding its use. From generation of a new design through to its commercialisation, designers and businesses using AI need to be aware of the challenges faced by a complex legal landscape.
This industry-driven event has been meticulously curated in collaboration with in-house counsels from pharmaceutical, biopharmaceutical, generic and biosimilar organizations. The focus? Identifying cutting-edge trends in international patent litigation that are shaping global pharma and biotech strategy.
The 40th edition of the Chamber’s Energy Transition survey – sponsored by KPMG and ETZ – has been tracking trends in the UK energy sector for two decades.